---
title: "Xishan Science&Technology: 441,800 restricted shares will be listed and circulated on June 6, 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241852576.md"
description: "Xishan Science&Technology announced that the total number of restricted shares for this listing is 441,800 shares, accounting for 0.9501% of the company's current total share capital. The lock-up period is 24 months from the date of the company's initial public offering and listing. The listing date for these shares is June 6, 2025, and there is 1 shareholder of the restricted shares, which is Shanghai Dongfang Securities Innovation Investment Co., Ltd"
datetime: "2025-05-26T11:59:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241852576.md)
  - [en](https://longbridge.com/en/news/241852576.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241852576.md)
generator: "portal-rs"
---

# Xishan Science&Technology: 441,800 restricted shares will be listed and circulated on June 6, 2025

Xishan Science&Technology announced that the total number of restricted shares for this listing is 441,800 shares, accounting for 0.9501% of the company's current total share capital. The lock-up period is 24 months from the date of the company's initial public offering and listing. The listing date for these shares is June 6, 2025, and there is 1 shareholder of the restricted shares, which is Shanghai Dongfang Securities Innovation Investment Co., Ltd

### Related Stocks

- [688576.CN](https://longbridge.com/en/quote/688576.CN.md)
- [03958.HK](https://longbridge.com/en/quote/03958.HK.md)

## Related News & Research

- [Women accounted for almost all of job gains in August. Here's why](https://longbridge.com/en/news/298065115.md)
- [Mabwell reports Phase Ib/IIa data showing anti-ST2 antibody 9MW1911 cuts COPD exacerbations up to 81%](https://longbridge.com/en/news/298042457.md)
- [12:09 ETHaier Biomedical präsentiert automatisierte Biolagerung und vernetzte Pharma-Lösungen auf der ISPE Singapore 2026](https://longbridge.com/en/news/297810393.md)
- [Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule](https://longbridge.com/en/news/297892535.md)
- [Khan demands Burnham block Heathrow expansion over net zero](https://longbridge.com/en/news/297836820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**